BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

407 related articles for article (PubMed ID: 17533052)

  • 41. The Runx genes: lineage-specific oncogenes and tumor suppressors.
    Cameron ER; Neil JC
    Oncogene; 2004 May; 23(24):4308-14. PubMed ID: 15156187
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Regulation of gene expression in peripheral T cells by Runx transcription factors.
    Djuretic IM; Cruz-Guilloty F; Rao A
    Adv Immunol; 2009; 104():1-23. PubMed ID: 20457114
    [TBL] [Abstract][Full Text] [Related]  

  • 43. AML1/ETO-induced survivin expression inhibits transcriptional regulation of myeloid differentiation.
    Balkhi MY; Christopeit M; Chen Y; Geletu M; Behre G
    Exp Hematol; 2008 Nov; 36(11):1449-60. PubMed ID: 18687517
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Interplay of RUNX1/MTG8 and DNA methyltransferase 1 in acute myeloid leukemia.
    Liu S; Shen T; Huynh L; Klisovic MI; Rush LJ; Ford JL; Yu J; Becknell B; Li Y; Liu C; Vukosavljevic T; Whitman SP; Chang KS; Byrd JC; Perrotti D; Plass C; Marcucci G
    Cancer Res; 2005 Feb; 65(4):1277-84. PubMed ID: 15735013
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Expression of AML1-d, a short human AML1 isoform, in embryonic stem cells suppresses in vivo tumor growth and differentiation.
    Aziz-Aloya RB; Levanon D; Karn H; Kidron D; Goldenberg D; Lotem J; Polak-Chaklon S; Groner Y
    Cell Death Differ; 1998 Sep; 5(9):765-73. PubMed ID: 10200536
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Histone deacetylase inhibitors induce the degradation of the t(8;21) fusion oncoprotein.
    Yang G; Thompson MA; Brandt SJ; Hiebert SW
    Oncogene; 2007 Jan; 26(1):91-101. PubMed ID: 16799637
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Physical and functional interaction of Runt-related protein 1 with hypoxia-inducible factor-1alpha.
    Peng ZG; Zhou MY; Huang Y; Qiu JH; Wang LS; Liao SH; Dong S; Chen GQ
    Oncogene; 2008 Jan; 27(6):839-47. PubMed ID: 17684492
    [TBL] [Abstract][Full Text] [Related]  

  • 48. ELA2 is regulated by hematopoietic transcription factors, but not repressed by AML1-ETO.
    Lausen J; Liu S; Fliegauf M; Lübbert M; Werner MH
    Oncogene; 2006 Mar; 25(9):1349-57. PubMed ID: 16247445
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The Runx1 transcription factor controls CSF-1-dependent and -independent growth and survival of macrophages.
    Himes SR; Cronau S; Mulford C; Hume DA
    Oncogene; 2005 Aug; 24(34):5278-86. PubMed ID: 16007221
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Lentiviral-mediated HoxB4 expression in human embryonic stem cells initiates early hematopoiesis in a dose-dependent manner but does not promote myeloid differentiation.
    Unger C; Kärner E; Treschow A; Stellan B; Felldin U; Concha H; Wendel M; Hovatta O; Aints A; Ahrlund-Richter L; Dilber MS
    Stem Cells; 2008 Oct; 26(10):2455-66. PubMed ID: 18617691
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Common gene expression signatures in t(8;21)- and inv(16)-acute myeloid leukaemia.
    Ichikawa H; Tanabe K; Mizushima H; Hayashi Y; Mizutani S; Ishii E; Hongo T; Kikuchi A; Satake M
    Br J Haematol; 2006 Nov; 135(3):336-47. PubMed ID: 16989659
    [TBL] [Abstract][Full Text] [Related]  

  • 52. RUNX1 DNA-binding mutants, associated with minimally differentiated acute myelogenous leukemia, disrupt myeloid differentiation.
    Cammenga J; Niebuhr B; Horn S; Bergholz U; Putz G; Buchholz F; Löhler J; Stocking C
    Cancer Res; 2007 Jan; 67(2):537-45. PubMed ID: 17234761
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The core-binding factor beta subunit is required for bone formation and hematopoietic maturation.
    Miller J; Horner A; Stacy T; Lowrey C; Lian JB; Stein G; Nuckolls GH; Speck NA
    Nat Genet; 2002 Dec; 32(4):645-9. PubMed ID: 12434155
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Coordinate regulation of cell growth and differentiation by TGF-beta superfamily and Runx proteins.
    Miyazono K; Maeda S; Imamura T
    Oncogene; 2004 May; 23(24):4232-7. PubMed ID: 15156178
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Leukemogenic AML1-ETO fusion protein increases carcinogen-DNA adduct formation with upregulated expression of cytochrome P450-1A1 gene.
    Xu M; Li D; Lu Y; Chen GQ
    Exp Hematol; 2007 Aug; 35(8):1249-55. PubMed ID: 17560011
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Transcriptional cross-regulation of RUNX1 by RUNX3 in human B cells.
    Spender LC; Whiteman HJ; Karstegl CE; Farrell PJ
    Oncogene; 2005 Mar; 24(11):1873-81. PubMed ID: 15688019
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Runx1 expression defines a subpopulation of displaced amacrine cells in the developing mouse retina.
    Stewart L; Potok MA; Camper SA; Stifani S
    J Neurochem; 2005 Sep; 94(6):1739-45. PubMed ID: 16026391
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Molecular pathways mediating MDS/AML with focus on AML1/RUNX1 point mutations.
    Harada Y; Harada H
    J Cell Physiol; 2009 Jul; 220(1):16-20. PubMed ID: 19334039
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Regulation of hematopoiesis by transcription factors].
    Kurokawa M; Hirai H
    Tanpakushitsu Kakusan Koso; 2000 Jun; 45(9 Suppl):1565-72. PubMed ID: 10879135
    [No Abstract]   [Full Text] [Related]  

  • 60. Small increases in the level of Sox2 trigger the differentiation of mouse embryonic stem cells.
    Kopp JL; Ormsbee BD; Desler M; Rizzino A
    Stem Cells; 2008 Apr; 26(4):903-11. PubMed ID: 18238855
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.